<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="bcdeafac-f4ef-4dda-bdb7-1f819c33bb76"><labelDrug name="SULAR"><Normalization><mmtx cui="C0723503" preferredWord="Sular" semType="phsu, orch"/></Normalization></labelDrug><generic name="Nisoldipine"/><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.1" text="SULAR (nisoldipine) tablet, film coated, extended release" type="negative"><entity charOffset="0:5" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.1.e.0" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="7:18" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.1.e.1" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="(nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.1.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.1.e.1"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2" text="SULAR (nisoldipine) is an extended release tablet dosage form of the dihydropyridine calcium channel blocker nisoldipine." type="negative"><entity charOffset="26:120" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.0" text="extended release tablet nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C1247156" phraseText="an extended release tablet dosage form of the dihydropyridine calcium channel blocker nisoldipine." preferredWord="Nisoldipine Extended Release Tablet" semType="clnd"/><RxNorm RxCui="284950"/></Normalization></entity><entity charOffset="7:18" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.1" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="(nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="69:108" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.2" text="dihydropyridine calcium channel blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C2945601" phraseText="an extended release tablet dosage form of the dihydropyridine calcium channel blocker nisoldipine." preferredWord="Dihydropyridine Calcium Channel Blocker [EPC]" semType="phsu"/><RxNorm RxCui="3427"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.3" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.2"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.2"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.1"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.2.e.2"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.4" text="SULAR is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers." type="negative"><entity charOffset="0:5" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.4.e.0" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="68:108" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.4.e.1" text="dihydropyridine calcium channel blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C2945601" phraseText="with known hypersensitivity to dihydropyridine calcium channel blockers." preferredWord="Dihydropyridine Calcium Channel Blocker [EPC]" semType="phsu"/><RxNorm RxCui="3427"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.4.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.4.e.1"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.9" text="In controlled studies of SULAR in patients with angina this was seen about 1.5% of the time in patients given nisoldipine, compared with 0.9% in patients given placebo." type="negative"><entity charOffset="110:121" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.9.e.0" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="nisoldipine," preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="25:30" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.9.e.1" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="of SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.9.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.9.e.0"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13" text="Because nisoldipine, like other vasodilators, decreases peripheral vascular resistance, careful monitoring of blood pressure during the initial administration and titration of SULAR is recommended. " type="negative"><entity charOffset="32:44" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.0" text="vasodilators" type="Biomedical_Entity"><Normalization><mmtx cui="C0042402" phraseText="like other vasodilators," preferredWord="Vasodilator Agents" semType="phsu"/><RxNorm RxCui="11146"/></Normalization></entity><entity charOffset="176:181" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.1" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="titration of SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="8:19" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.2" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="nisoldipine," preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.1"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.1"/></sentence><sentence biomedicalEntities="1" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.14" lineNumber="21" text="Close observation is especially important for patients already taking medications that are known to lower blood pressure. " type="irregular"><entity charOffset="70:120" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.14.e.0" text="medications that are known to lower blood pressure" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="especially important for patients already taking medications" preferredWord="Pharmaceutical Preparations" semType="phsu"/><RxNorm RxCui="691673"/></Normalization></entity><entity charOffset="0:17" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.14.e.1" text="Close observation" type="Caution_Interaction"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.14.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.14.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.14.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13" text="Because nisoldipine, like other vasodilators, decreases peripheral vascular resistance, careful monitoring of blood pressure during the initial administration and titration of SULAR is recommended. "><entity charOffset="8:19" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.13.e.0" text="nisoldipine" type="Drug"><Normalization><mmtx cui="C0028116" phraseText="nisoldipine," preferredWord="Nisoldipine" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.14.e.0"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.18" text="Although acute hemodynamic studies of nisoldipine in patients with NYHA Class II-IV heart failure have not demonstrated negative inotropic effects, safety of SULAR in patients with heart failure has not been established. " type="negative"><entity charOffset="158:163" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.18.e.0" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="safety of SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="38:49" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.18.e.1" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="acute hemodynamic studies of nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.18.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.18.e.0"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.19" text="Caution therefore should be exercised when using SULAR in patients with heart failure or compromised ventricular function, particularly in combination with a beta-blocker." type="negative"><entity charOffset="49:54" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.19.e.0" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="SULAR in patients" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="158:170" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.19.e.1" text="beta-blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="with a beta-blocker." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.19.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.19.e.1"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.21" text="Because nisoldipine is extensively metabolized by the liver and, in patients with cirrhosis, it reaches blood concentrations about 5 times those in normals, SULAR should be administered cautiously in patients with severe hepatic dysfunction (See DOSAGE AND ADMINISTRATION)." type="negative"><entity charOffset="8:19" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.21.e.0" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="157:162" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.21.e.1" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.21.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.21.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26" lineNumber="33" text="Grapefruit juice, which has been shown to increase significantly the bioavailability of nisoldipine and other dihydropyridine type calcium channel blockers, should not be taken with SULAR." type="regular"><entity charOffset="0:16" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.0" text="Grapefruit juice" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="Grapefruit juice," preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="42:50|69:84" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.1" text="increase bioavailability" type="Increase_Interaction"/><entity charOffset="88:99" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.3" text="nisoldipine" type="Drug"><Normalization><mmtx cui="C0028116" phraseText="the bioavailability of nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="110:155" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.4" text="dihydropyridine type calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C2945601" phraseText="other dihydropyridine type calcium channel blockers," preferredWord="Dihydropyridine Calcium Channel Blocker [EPC]" semType="phsu"/><RxNorm RxCui="3427"/></Normalization></entity><drugClassMembership drug="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.3" drugClass="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.4"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.4" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.26.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34" lineNumber="43" text="A 30 to 45% increase in AUC and Cmax of nisoldipine was observed with concomitant administration of cimetidine 400 mg twice daily. " type="regular"><entity charOffset="100:110" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.0" text="cimetidine" type="Drug"><Normalization><mmtx cui="C0984915" phraseText="observed with concomitant administration of cimetidine 400 mg twice daily." preferredWord="Cimetidine 400 MG" semType="clnd"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="40:51" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.1" text="nisoldipine" type="Drug"><Normalization><mmtx cui="C0028116" phraseText="Cmax of nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="12:27" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.2" text="increase in AUC" type="Increase_Interaction"/><entity charOffset="12:23|32:36" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.4" text="increase in Cmax" type="Increase_Interaction"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.2"><relations><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.ddi.2"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.4"><relations><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.0" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.34.e.2" type="Increase_Interaction"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.35" text="Ranitidine 150 mg twice daily did not interact significantly with nisoldipine (AUC was decreased by 15 - 20%). " type="negative"><entity charOffset="0:17" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.35.e.0" text="ranitidine 150 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C1123414" phraseText="Ranitidine 150 mg twice daily" preferredWord="Ranitidine 150 MG" semType="clnd"/><RxNorm RxCui="203136"/></Normalization></entity><entity charOffset="66:77" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.35.e.1" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="significantly with nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.35.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.35.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38" lineNumber="47" text="SULAR is substrate of CYP3A4 and coadministration of SULAR with any known inducer or inhibitor of CYP3A4 should be avoided in general." type="regular"><entity charOffset="53:58" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.0" text="SULAR" type="Drug"><Normalization><mmtx cui="C0723503" phraseText="coadministration of SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="115:122" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.1" text="avoided" type="Caution_Interaction"/><entity charOffset="74:81|95:104" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.3" text="inducer of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="993159"/></Normalization></entity><entity charOffset="85:94|95:104" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.4" text="inhibitor of CYP3A4" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.3" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.4" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.38.e.4"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39" lineNumber="49" text="Coadministration of phenytoin with a dose bioequivalent to 34 mg SULAR tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels. " type="regular"><entity charOffset="20:29" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.0" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="Coadministration of phenytoin" preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="82:100" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.1" text="epileptic patients" type="SPAN"><Normalization><mmtx cui="C0014544" phraseText="in epileptic patients" preferredWord="Epilepsy" semType="dsyn"/></Normalization></entity><entity charOffset="113:124" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.2" text="nisoldipine" type="Drug"><Normalization><mmtx cui="C0028116" phraseText="the nisoldipine plasma concentrations to undetectable levels." preferredWord="Nisoldipine" semType="phsu, orch"/><mmtx cui="C0028116" phraseText="the nisoldipine plasma concentrations to undetectable levels." preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="101:112|125:146" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.3" text="lowered the plasma concentrations" type="Decrease_Interaction"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.3"><relations><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.0"/></relation><relation type="hasContext"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.1" ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.2" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.39.e.3" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40" lineNumber="49" text="Coadministration of SULAR with phenytoin should be avoided and alternative antihypertensive therapy should be considered. " type="regular"><entity charOffset="20:25" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.0" text="SULAR" type="Drug"><Normalization><mmtx cui="C0723503" phraseText="Coadministration of SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="31:40" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.1" text="phenytoin" type="Drug"><Normalization><mmtx cui="C0031507" phraseText="with phenytoin" preferredWord="Phenytoin" semType="phsu, orch"/><RxNorm RxCui="8183"/></Normalization></entity><entity charOffset="51:58" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.2" text="avoided" type="Caution_Interaction"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.1" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.40.e.2" type="Caution_Interaction"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41" text="Pharmacokinetic interactions between nisoldipine and beta-blockers (atenolol, propranolol) were variable and not significant. " type="negative"><entity charOffset="78:89" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.0" text="propranolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0033497" phraseText="propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="53:66" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.1" text="beta-blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blockers" preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="68:76" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.2" text="atenolol" type="Biomedical_Entity"><Normalization><mmtx cui="C0004147" phraseText="(atenolol," preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><entity charOffset="37:48" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.3" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="Pharmacokinetic interactions between nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.2"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.1"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.41.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42" lineNumber="49" text="Propranolol attenuated the heart rate increase following administration of immediate release nisoldipine. " type="regular"><entity charOffset="0:11" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.0" text="Propranolol" type="Drug"><Normalization><mmtx cui="C0033497" phraseText="Propranolol" preferredWord="Propranolol" semType="phsu, orch"/><RxNorm RxCui="82084"/></Normalization></entity><entity charOffset="75:104" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.1" text="immediate release nisoldipine" type="Drug"><Normalization><mmtx cui="C0028116" phraseText="administration of immediate release nisoldipine." preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="1023968"/></Normalization></entity><entity charOffset="12:46" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.2" text="attenuated the heart rate increase" type="Specific_Interaction"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.1" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.42.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43" lineNumber="49" text="The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy. " type="regular"><entity charOffset="29:34" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.0" text="SULAR" type="Drug"><Normalization><mmtx cui="C0723503" phraseText="The blood pressure effect of SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="71:79" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.1" text="atenolol" type="Drug"><Normalization><mmtx cui="C0004147" phraseText="on atenolol" preferredWord="Atenolol" semType="phsu, orch"/><RxNorm RxCui="1202"/></Normalization></entity><entity charOffset="4:25|35:55" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.2" text="blood pressure effect tended to be greater" type="Specific_Interaction"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.2"><relations><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.1" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.43.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44" lineNumber="49" text="Quinidine at 648 mg bid decreased the bioavailability (AUC) of nisoldipine by 26%, but not the peak concentration. " type="regular"><entity charOffset="0:9" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.0" text="Quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="Quinidine at 648 mg bid" preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="24:59" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.1" text="decreased the bioavailability (AUC)" type="Decrease_Interaction"/><entity charOffset="63:74" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.3" text="nisoldipine" type="Drug"><Normalization><mmtx cui="C0028116" phraseText="(AUC) of nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.1"><relations><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.3" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.44.e.1" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45" lineNumber="49" text="Immediate release nisoldipine increased plasma quinidine concentrations by about 20%. " type="regular"><entity charOffset="0:29" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.0" text="Immediate release nisoldipine" type="Drug"><Normalization><mmtx cui="C0028116" phraseText="Immediate release nisoldipine increased plasma quinidine concentrations by about 20%." preferredWord="Nisoldipine" semType="phsu, orch"/><mmtx cui="C0028116" phraseText="Immediate release nisoldipine increased plasma quinidine concentrations by about 20%." preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="1023968"/></Normalization></entity><entity charOffset="30:46|57:71" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.1" text="increased plasma concentrations" type="Increase_Interaction"/><entity charOffset="47:56" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.3" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="Immediate release nisoldipine increased plasma quinidine concentrations by about 20%." preferredWord="Quinidine" semType="phsu, orch"/><mmtx cui="C0034414" phraseText="Immediate release nisoldipine increased plasma quinidine concentrations by about 20%." preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.3" trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.45.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47" text="No significant interactions were found between nisoldipine and warfarin of digoxin." type="negative"><entity charOffset="63:71" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin of digoxin." preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="75:82" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.1" text="digoxin" type="Biomedical_Entity"><Normalization><mmtx cui="C0012265" phraseText="warfarin of digoxin." preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="47:58" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.2" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="found between nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.1"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.47.e.1"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49" text="Dietary administration of nisoldipine to male and female rats for up to 24 months (mean doses up to 82 and 111 mg/kg/day, 16 and 19 times the maximum recommended human dose [MRHD] on a mg/m2 basis, respectively and female mice for up to 21 months (mean doses of up to 217 mg/kg/day, 20 times the MRHD on a mg/m2 basis) revealed no evidence of tumorigenic effect of nisoldipine. " type="negative"><entity charOffset="191:196" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis," preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="365:376" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.1" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="no evidence of tumorigenic effect of nisoldipine." preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="312:317" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.2" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="26:37" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.3" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="Dietary administration of nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.1"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.1"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.49.e.2"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.50" text="In male mice receiving a mean dose of 163 mg nisoldipine/kg/day (16 times the MRHD of 60 mg/day on a mg/m2 basis), an increased frequency of stomach papilloma, but still within the historical range, was observed. " type="negative"><entity charOffset="107:112" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.50.e.0" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="45:56" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.50.e.1" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="a mean dose of 163 mg nisoldipine/kg/day" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.50.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.50.e.0"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.53" text="When administered to male and female rats at doses of up to 30 mg/kg/day (about 5 times the MRHD on a mg/m2 basis) nisoldipine had no effect on fertility." type="negative"><entity charOffset="115:126" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.53.e.0" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="nisoldipine" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="108:113" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.53.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="the MRHD on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.53.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.53.e.0"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60" text="In a study in which pregnant monkeys (both treated and control) had high rates of abortion and mortality, the only surviving fetus from a group exposed to a maternal dose of 100 mg nisoldipine/kg/day (about 30 times the MRHD when compared on a mg/m2 basis) presented with forelimb and vertebral abnormalities not previously seen in control monkeys of the same strain. " type="negative"><entity charOffset="181:192" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.0" text="nisoldipine" type="Biomedical_Entity"><Normalization><mmtx cui="C0028116" phraseText="exposed to a maternal dose of 100 mg nisoldipine/kg/day" preferredWord="Nisoldipine" semType="phsu, orch"/><RxNorm RxCui="7435"/></Normalization></entity><entity charOffset="250:255" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.1" text="basis" type="Biomedical_Entity"><Normalization><mmtx cui="C1874451" phraseText="compared on a mg/m2 basis" preferredWord="Basis" semType="phsu"/><RxNorm RxCui="1046801"/></Normalization></entity><entity charOffset="115:124" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.2" text="surviving" type="Biomedical_Entity"><Normalization><mmtx cui="C0310255" phraseText="surviving" preferredWord="SURVIVE" semType="phsu"/><RxNorm RxCui="9671"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.1"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.2" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.60.e.1"/></sentence><sentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79" text="SULAR has been used safely with diuretics, ACE inhibitors, and beta-blocking agents. " type="negative"><entity charOffset="43:57" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.1" text="sular" type="Biomedical_Entity"><Normalization><mmtx cui="C0723503" phraseText="SULAR" preferredWord="Sular" semType="phsu, orch"/><RxNorm RxCui="220081"/></Normalization></entity><entity charOffset="63:83" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.2" text="beta-blocking agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0001645" phraseText="beta-blocking agents." preferredWord="Adrenergic beta-Antagonists" semType="phsu"/><RxNorm RxCui="371"/></Normalization></entity><entity charOffset="32:41" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.3" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="safely with diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.0" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.2"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.0"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.2"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.1" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.3"/><pair ddi="false" e1="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.3" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.79.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.85" lineNumber="75" text="Grapefruit products should be avoided before and after dosing. " type="irregular"><entity charOffset="0:19" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.85.e.0" text="Grapefruit products" type="Substance"><Normalization><mmtx cui="C0440280" phraseText="Grapefruit products" preferredWord="GRAPEFRUIT EXTRACT" semType="phsu, orch"/><RxNorm RxCui="124323"/></Normalization></entity><entity charOffset="30:37" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.85.e.1" text="avoided" type="Caution_Interaction"/><drugInteraction id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.85.ddi.1"><interaction trigger="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.85.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.85.e.0"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.84" text="SULAR should be taken on an empty stomach (1 hour before or 2 hours after a meal). "><entity charOffset="0:5" id="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.84.e.0" text="SULAR" type="Drug"><Normalization><mmtx cui="C0723503" phraseText="SULAR" preferredWord="Sular" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.bcdeafac-f4ef-4dda-bdb7-1f819c33bb76.s.85.e.0"/></sentence><positiveExamples number="12"/><negativeExamples number="41"/></document>